This study showed a significant correlation between MZ supplementation and decreased the risk of fatty liver and CMS and has implication in the management of fatty liver and insulin resistance by regulating PPAR-γ, IRS-1, NF-κB and Nrf2 pathways. This evidence concerns the gene NFE2L2 and fatty liver disease.